2022 Compounding Controlled Substances 
Pharmacy Times
AUGUST 6, 2025
SHOW MORE The FDA targets 7-hydroxymitragynine, a potent kratom derivative, as a controlled substance due to its opioid-like effects and rising health risks. FDA recommends 7-OH compound found in vapes be controlled. Published March 25, 2022. Reuters Staff. link] Published July 29, 2025. Accessed August 6, 2025.
Beckers Hospital Review
AUGUST 13, 2025
Mr. Clinton has grown revenue from regional group purchasing organization and affiliate activities at a 30% compound annual growth rate for four consecutive years. In 2022, she was selected as the program director overseeing the deployment of new financial, human capital management and supply chain modules. Kevin Gordon.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
SEPTEMBER 5, 2022
According to Kasada, in April 2022 its threat intelligence observed the use of credential stuffing – the automated injection of stolen username and password pairs into a website’s login form – to attack pharmacies, steal active customer accounts, and exploit them for the distribution of prescribed medications.
European Pharmaceutical Review
DECEMBER 21, 2022
Most psychedelic drugs are Schedule I controlled substances, which means that very strict legal and regulatory controls accompany their use” Some psychedelics originate in nature and have been used by Indigenous cultures for thousands of years; others are manipulated or manufactured.
Pharmaceutical Technology
DECEMBER 5, 2022
In 2022, a surge in the pipeline has led to cannabinoid receptors becoming the most popular target in preclinical development. Cannabinoid-based drugs are derived from compounds found in the cannabis plant. However, at the federal level, cannabinoids remain illegal under the Controlled Substances Act.
FDA Law Blog: Biosimilars
AUGUST 21, 2023
Attorney’s Office for the Western District of Texas announced that People’s Rx, a local chain operating five retail pharmacies and a compounding laboratory in the Austin area, agreed to pay $200,000 to settle allegations that it violated the Controlled Substances Act (“CSA”). 16, 2023 ( DOJ Press Release ).
The Happy PharmD
OCTOBER 11, 2024
Over the decades, it transformed into a pharmacy powerhouse, expanding through strategic acquisitions to over 2,000 stores by 2022. Compounding its challenges, Rite Aid became entangled in legal issues, notably linked to the opioid crisis.
Expert insights. Personalized for you.
Let's personalize your content